DAPAFLOZIN 10

Dapaflozin 10 mg is an oral antidiabetic medication belonging to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors). It helps manage Type 2 Diabetes Mellitus by reducing excess blood sugar levels through the kidneys and promoting glucose excretion in urine. In addition to improving glycemic control, Dapaflozin also supports weight loss and cardiovascular health in diabetic patients.

Key Benefits:

• Helps lower blood sugar levels in adults with Type 2 Diabetes

• Aids in weight reduction and blood pressure control

• Supports heart and kidney health in diabetic patients

• Works independently of insulin pathway – low risk of hypoglycemia